Immune thrombocytopenia secondary to COVID-19: a systematic review
S Bhattacharjee, M Banerjee - SN comprehensive clinical medicine, 2020 - Springer
Immune thrombocytopenia, often known as immune thrombocytopenic purpura (ITP), has
emerged as an important complication of COVID-19. A systematic review was done to …
emerged as an important complication of COVID-19. A systematic review was done to …
How we treat primary immune thrombocytopenia in adults
X Liu, Y Hou, M Hou - Journal of Hematology & Oncology, 2023 - Springer
Primary immune thrombocytopenia (ITP) is an immune-mediated bleeding disorder
characterized by decreased platelet counts and an increased risk of bleeding. Multiple …
characterized by decreased platelet counts and an increased risk of bleeding. Multiple …
Guidelines on the Use of therapeutic apheresis in clinical practice–Evidence‐Based approach from the Writing Committee of the American Society for Apheresis: The …
L Connelly‐Smith, CR Alquist, NA Aqui… - Journal of clinical …, 2023 - Wiley Online Library
Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …
Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update
BJ Schneider, J Naidoo, BD Santomasso… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE To increase awareness, outline strategies, and offer guidance on the
recommended management of immune-related adverse events (irAEs) in patients treated …
recommended management of immune-related adverse events (irAEs) in patients treated …
Immune thrombocytopenic purpura in a patient with Covid-19
AA Zulfiqar, N Lorenzo-Villalba… - New England Journal …, 2020 - Mass Medical Soc
Immune Thrombocytopenic Purpura in a Patient with Covid-19 | New England Journal of Medicine
Skip to main content The New England Journal of Medicine homepage Advanced Search …
Skip to main content The New England Journal of Medicine homepage Advanced Search …
Rilzabrutinib, an oral BTK inhibitor, in immune thrombocytopenia
DJ Kuter, M Efraim, J Mayer, M Trněný… - … England Journal of …, 2022 - Mass Medical Soc
Background Rilzabrutinib, an oral, reversible covalent inhibitor of Bruton's tyrosine kinase,
may increase platelet counts in patients with immune thrombocytopenia by means of dual …
may increase platelet counts in patients with immune thrombocytopenia by means of dual …
[HTML][HTML] Mycophenolate mofetil for first-line treatment of immune thrombocytopenia
CA Bradbury, J Pell, Q Hill, C Bagot… - … England Journal of …, 2021 - Mass Medical Soc
Background Immune thrombocytopenia is a rare autoimmune disorder with associated
bleeding risk and fatigue. Recommended first-line treatment for immune thrombocytopenia …
bleeding risk and fatigue. Recommended first-line treatment for immune thrombocytopenia …
[HTML][HTML] Immune thrombocytopenia in a 22‐year‐old post Covid‐19 vaccine
O Tarawneh, H Tarawneh - American journal of hematology, 2021 - ncbi.nlm.nih.gov
To the Editor: A 22-year-old healthy male with no medication use received the Pfizer-
BioNTech BNT16B2b2 mRNA vaccine through his work as an emergency department …
BioNTech BNT16B2b2 mRNA vaccine through his work as an emergency department …
Asplenia and spleen hypofunction
Asplenia (the congenital or acquired absence of the spleen) and hyposplenism (defective
spleen function) are common causes of morbidity and mortality. The spleen is a secondary …
spleen function) are common causes of morbidity and mortality. The spleen is a secondary …
An update on the pathophysiology of immune thrombocytopenia
Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder mediated by
antiplatelet autoantibodies and antigen-specific T cells that either destroy platelets …
antiplatelet autoantibodies and antigen-specific T cells that either destroy platelets …